Manufacturing
AMEMS GMP manufacturing facility support our commercial launches, The facility utilizes the latest single-use technologies from vial to vial by having ultra modern production facilities incorporating latest state of the art technology with a combination of technically qualified personnel and experienced workforce. It makes us comparable to any Multinational Company and eligible for any international inspection.
AMEMS is involved in the Technology, Manufacture, and Marketing of Specialized Therapeutic molecules. Its initial vision is to cater the developing world Market and then register MENA, CIS and EMEA markets through partnering companies and associates.. The manufacturing facility has State-of-the-Art machinery to manufacture oral dose, liquid , powder and injectable Liquid and Lyophilized products.
Some other features of our facility:
- Modern QA, QC, Microbiological and PD Lab supported with high-tech equipment.
- Modern QA, QC, Microbiological and PD Lab supported with high-tech equipment.
- Fully automated with electronically controlled operating system as per GAMP-4 (Good Automated Manufacturing Practice) guidelines.
- Sophisticated Effluent Treatment Plant (ETP)
- Conforms to international environmental, health & safety regulations.
The Facility Highlights include:
- State of the art cGMP Facility
- Vial to vial single-use technology and closed processing
- lean steam, process chiller, central CIP, or WFI generation in design
- Fill volume from 2.0 to 100ml with IPC
- Lypholizer with 7.5M3
- Equipment and Instruments are SCADA 21-CFR Compliant
- Facility Access using Siemens Bio-Metric Control and Building management System
- Environmental Monitoring using Continuous SMA and PMS systems.
- MENA/ASIA Marketing and Sales
- Contract Filling Available